These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 20335424

  • 1. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
    Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN.
    J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT, Lovero G, Coretti C, Martinelli D, De Giglio O, Iatta R, Balbino S, Rosato A, Caggiano G.
    BMC Microbiol; 2015 May 20; 15():106. PubMed ID: 25990252
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J, Diekema DJ.
    J Clin Microbiol; 2010 Jan 20; 48(1):52-6. PubMed ID: 19923478
    [Abstract] [Full Text] [Related]

  • 5. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN.
    Diagn Microbiol Infect Dis; 2014 Jun 20; 79(2):198-204. PubMed ID: 24736096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
    Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, Tendolkar S, Diekema D.
    J Clin Microbiol; 2011 Feb 20; 49(2):624-9. PubMed ID: 21147948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 20; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 11. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
    Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J.
    Antimicrob Agents Chemother; 2013 Dec 20; 57(12):5836-42. PubMed ID: 24018263
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.
    Arendrup MC, Park S, Brown S, Pfaller M, Perlin DS.
    Antimicrob Agents Chemother; 2011 May 20; 55(5):1891-5. PubMed ID: 21357293
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.
    Vale-Silva LA, Pinto P, Lopes V, Ramos H, Pinto E.
    Eur J Clin Microbiol Infect Dis; 2012 Jun 20; 31(6):941-6. PubMed ID: 21909651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.
    Arendrup MC, Rodriguez-Tudela JL, Park S, Garcia-Effron G, Delmas G, Cuenca-Estrella M, Gomez-Lopez A, Perlin DS.
    Antimicrob Agents Chemother; 2011 Apr 20; 55(4):1580-7. PubMed ID: 21245440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.
    Pfaller MA, Messer SA, Diekema DJ, Jones RN, Castanheira M.
    J Clin Microbiol; 2014 Jan 20; 52(1):108-14. PubMed ID: 24153129
    [Abstract] [Full Text] [Related]

  • 18. Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.
    Meletiadis J, Geertsen E, Curfs-Breuker I, Meis JF, Mouton JW.
    Antimicrob Agents Chemother; 2016 Oct 20; 60(10):6173-8. PubMed ID: 27480850
    [Abstract] [Full Text] [Related]

  • 19. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria.
    Pfaller MA, Diekema DJ, Jones RN, Castanheira M.
    J Clin Microbiol; 2014 Sep 20; 52(9):3223-9. PubMed ID: 24951808
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.
    J Clin Microbiol; 2008 Jan 20; 46(1):150-6. PubMed ID: 18032613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.